Eli Lilly and Co (NYSE:LLY)

204.71
Delayed Data
As of Feb 26
 +0.89 / +0.44%
Today’s Change
117.06
Today|||52-Week Range
218.00
+21.24%
Year-to-Date
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
Feb 26 / Zacks.com - Paid Partner Content
4 Healthcare Stocks to Buy and Hold for the Long Term
Feb 24 / StockNews.com - Paid Partner Content
Radius' (RDUS) Q4 Loss Wider Than Expected, Revenues Beat
Feb 26 / Zacks.com - Paid Partner Content
2 Large Cap Stocks to Buy for Income and Growth Amid Tech Volatility
Feb 23 / Zacks.com - Paid Partner Content
Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track
Feb 26 / Zacks.com - Paid Partner Content
Big Pharma Short Percentage Is Below Overall Market
Feb 23 / GuruFocus News - Paid Partner Content
Merck Makes Another Move to Beef Up Drug Business
Feb 25 / GuruFocus News - Paid Partner Content
FDA Issues New Guidelines for COVID-19 Vaccines, Tests, Drugs
Feb 23 / Zacks.com - Paid Partner Content
United Therapeutics (UTHR) Q4 Earnings Miss, Sales Beat
Feb 25 / Zacks.com - Paid Partner Content
Should You Follow Cathie Wood Into This Coronavirus Stock?
Feb 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close203.82
Today’s open201.78
Day’s range202.09 - 206.99
Volume3,887,878
Average volume (3 months)4,325,041
Market cap$192.6B
Data as of 4:50pm ET, 02/26/2021

Growth & Valuation

Earnings growth (last year)+36.99%
Earnings growth (this year)+4.03%
Earnings growth (next 5 years)+13.20%
Revenue growth (last year)+9.95%
P/E ratio30.2
Price/Sales6.28
Price/Book34.07

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.80-0.92%
ABBVAbbVie+0.40+0.37%
MRKMerck-1.97-2.64%
PFEPfizer-0.34-1.01%
Data as of 6:08pm ET, 02/26/2021

Financials

Next reporting dateApril 27, 2021
EPS forecast (this quarter)$2.19
Annual revenue (last year)$24.5B
Annual profit (last year)$6.2B
Net profit margin25.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Indianapolis, Indiana

Forecasts